Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. An experimental medicine from Cytokinetics improved exercise capacity more than …
Read More »Cytokinetics drug posts strong results in patients with heart condition
